Interferon therapy for hepatitis C

Lancet

Volumn 348, Issue 9033, 1996, Pages 973-974

  Preston, H ^a   Wright, T L ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

HEPATITIS C; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029800472     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64920-3     Document Type: Note

References (6)

1. MJ Tong NS El-Farra AR Reikes RL Co Clinical outcomes after transfusion-associated hepatitis C N Engl J Med 332 1995 1463 1466
2. LB Seeff Z Buskell-Bales EC Wright Long-term mortality after transfusion-associated non-A, non-B hepatitis N Engl J Med 327 1992 1906 1911
3. GL Davis Prediction of response to interferon treatment of chronic hepatitis C JHepatology 21 1994 1 3
4. J-M Pawlotsky F Roudot-Thoraval A Bastie Factors affecting treatment responses to interferon-a in chronic hepatitis C J Infect Dis 174 1996 1 7
5. T Poynard P Bedossa M Chevallier A comparison of three interferon alfa-2b regimens for the long-term treatmentof chronic non-A, non-B hepatitis N EnglJ Med 332 1995 1457 1462
6. S Sherlock Antiviral therapy for chronic hepatitis C viral infection J Hepatology 23 suppl 2 1995 3 7